You are here

  • Home
  • Archive
  • Volume 29, Issue Suppl 3
  • 2 Exploratory analysis of postprogression and patient-centered outcomes in ariel3: a phase 3, randomized, placebo-controlled study of rucaparib maintenance treatment in patients with recurrent ovarian carcinoma

Article metrics

Article menu

Download PDFPDF

Plenary sessions
Plenary 1
IGCS19-0455
2 Exploratory analysis of postprogression and patient-centered outcomes in ariel3: a phase 3, randomized, placebo-controlled study of rucaparib maintenance treatment in patients with recurrent ovarian carcinoma
Free

 

Online download statistics by month:

Online download statistics by month: September 2019 to October 2024

AbstractFullPdf
Sep 20192009
Oct 201986014
Nov 201914022
Dec 201935020
Jan 20203008
Feb 202022014
Mar 202046011
Apr 20206602
May 20204507
Jun 202056010
Jul 20204204
Aug 20201805
Sep 20201402
Oct 20202107
Nov 2020901
Dec 2020802
Jan 2021502
Feb 2021402
Mar 20213505
Apr 2021601
May 2021503
Jun 2021303
Jul 2021004
Aug 2021104
Sep 2021205
Oct 20216018
Nov 202137014
Dec 20212002
Jan 20221403
Feb 20222000
Mar 2022500
Apr 2022905
May 20221206
Jun 2022706
Jul 20221603
Aug 20221408
Sep 20221806
Oct 20222004
Nov 2022804
Dec 20221201
Jan 2023904
Feb 2023800
Mar 20231000
Apr 2023501
May 2023201
Jun 2023702
Jul 20232004
Aug 2023301
Sep 2023803
Oct 20231001
Nov 20232109
Dec 20232900
Jan 20242002
Feb 2024804
Mar 202418038
Apr 2024605
May 2024800
Jun 2024800
Jul 2024801
Aug 2024604
Sep 2024700
Oct 2024600
Total10380327